title: Mechanisms of cerebrovascular protection: oestrogen, inflammation and mitochondria.
abstract: Investigation of oestrogen action reveals a multitude of diverse effects. This brief review focuses on the impact of oestrogen on the vasculature, with particular emphasis on the cerebral circulation. Three major actions of oestrogen are discussed: enhancement of vasodilator capacity, suppression of vascular inflammation and increase in mitochondrial efficiency. In both humans and animals, oestrogen increases vasodilator tone, an effect dependent on a functional endothelium. Two distinct mechanisms are involved: increase in endothelial nitric oxide synthase (eNOS) mRNA and protein and phosphorylation of eNOS via the PI-3 kinase/Akt pathway. Both effects are mediated by oestrogen receptors (ER), but through two pathways, ER-mediated nuclear gene transcription and cell membrane-associated ERs respectively. Oestrogen also increases function of other endothelium-dependent vasodilators. Oestrogen suppresses vascular inflammation through an NF-κB-dependent effect. The inflammatory response has also been shown to vary significantly during the oestrous cycle of rodents. Emerging information shows that oestrogen increases mitochondrial biogenesis and decreases superoxide production. Suppression of mitochondrial superoxide production by 17β-estradiol in cerebral blood vessels is mediated by the ER-alpha receptor and not dependent on increased Mn superoxide dismutase activity. Oestrogen treatment also increases protein levels for a number of components of the electron transfer chain, as well as levels of transcription factors that regulate mitochondrial function. All of these actions of oestrogen could be important in mediating vascular protection, especially in the cerebral circulation. Furthermore, given the potential of mitochondrial DNA damage to contribute to pathophysiology and ageing, mitochondrial protective effects of oestrogen might contribute to the longer average lifespan of women.
authors.affiliation: Department of Pharmacology, School of Medicine, University of California, Irvine, 92697-4625, USA. spduckle@uci.edu
authors.forename: S P
authors.initials: SP
authors.lastname: Duckles
authors.forename: D N
authors.initials: DN
authors.lastname: Krause
mesh_terms: D000818:Animals; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology*; D004967:Estrogens / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*
chemical_list: D004967:Estrogens
references.citation: J Appl Physiol (1985). 2006 Oct;101(4):1252-61
references.pmid: 16794020
references.citation: J Cereb Blood Flow Metab. 2010 Mar;30(3):545-54
references.pmid: 19861973
references.citation: Hypertension. 2003 Nov;42(5):991-6
references.pmid: 14581292
references.citation: Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H588-94
references.pmid: 15277199
references.citation: Clin Exp Pharmacol Physiol. 2007 Aug;34(8):801-8
references.pmid: 17600562
references.citation: J Appl Physiol (1985). 2006 Jan;100(1):328-35
references.pmid: 16357086
references.citation: Endocr Rev. 2003 Jun;24(3):313-40
references.pmid: 12788802
references.citation: Am J Physiol Heart Circ Physiol. 2004 May;286(5):H2010-9
references.pmid: 14684367
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16468-73
references.pmid: 17921256
references.citation: Ann N Y Acad Sci. 2005 Jun;1052:43-56
references.pmid: 16024750
references.citation: Genes Dev. 2004 Feb 15;18(4):357-68
references.pmid: 15004004
references.citation: Mol Pharmacol. 2005 Jan;67(1):105-13
references.pmid: 15496504
references.citation: Eur J Pharmacol. 2003 Sep 30;478(1):35-8
references.pmid: 14555182
references.citation: Steroids. 2005 May-Jun;70(5-7):382-7
references.pmid: 15862821
references.citation: Neuroreport. 2002 Aug 7;13(11):1469-72
references.pmid: 12167775
references.citation: Ann N Y Acad Sci. 2008 Dec;1147:321-34
references.pmid: 19076454
references.citation: Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H241-50
references.pmid: 12637362
references.citation: Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E261-7
references.pmid: 16492687
references.citation: Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2333-40
references.pmid: 17208996
references.citation: Obstet Gynecol. 2005 Aug;106(2):219-26
references.pmid: 16055568
references.citation: J Pharmacol Exp Ther. 2008 Jun;325(3):782-90
references.pmid: 18354059
references.citation: Annu Rev Genet. 2005;39:359-407
references.pmid: 16285865
references.citation: Circ Res. 2003 Nov 28;93(11):1127-33
references.pmid: 14592997
references.citation: Am J Respir Cell Mol Biol. 2002 May;26(5):610-6
references.pmid: 11970914
references.citation: Endocr Rev. 2006 Oct;27(6):575-605
references.pmid: 16763155
references.citation: Mol Interv. 2006 Feb;6(1):26-35
references.pmid: 16507748
references.citation: Mol Pharmacol. 2005 Oct;68(4):959-65
references.pmid: 15994367
references.citation: Circ Res. 1996 Nov;79(5):1024-30
references.pmid: 8888695
references.citation: Circulation. 2004 Jan 27;109(3):433-8
references.pmid: 14744958
references.citation: J Clin Invest. 1998 Jul 1;102(1):176-83
references.pmid: 9649571
references.citation: FEBS Lett. 2003 Jul 17;547(1-3):75-9
references.pmid: 12860389
references.citation: Circulation. 2004 Sep 21;110(12):1664-9
references.pmid: 15353495
references.citation: Stroke. 1999 Oct;30(10):2186-90
references.pmid: 10512927
references.citation: J Am Coll Cardiol. 1992 Aug;20(2):452-7
references.pmid: 1634685
references.citation: J Cell Biochem. 2008 Dec 15;105(6):1342-51
references.pmid: 18846505
references.citation: J Physiol. 2009 Nov 1;587(Pt 21):5019-23
references.pmid: 19687123
references.citation: Trends Pharmacol Sci. 2007 Jun;28(6):263-70
references.pmid: 17466385
references.citation: Biochim Biophys Acta. 2009 Oct;1793(10):1540-70
references.pmid: 19559056
references.citation: Pflugers Arch. 2010 May;459(6):841-51
references.pmid: 20213497
references.citation: Pharmacol Rev. 2008 Jun;60(2):210-41
references.pmid: 18579753
references.citation: J Appl Physiol (1985). 2001 Nov;91(5):2391-9; discussion 2389-90
references.pmid: 11641386
references.citation: Lancet. 2005 Apr 16-22;365(9468):1415-28
references.pmid: 15836891
references.citation: Mol Endocrinol. 2008 Mar;22(3):609-22
references.pmid: 18048642
references.citation: Am J Physiol. 1998 Jul;275(1):H292-300
references.pmid: 9688926
references.citation: Am J Physiol. 1998 Nov;275(5):R1571-7
references.pmid: 9791075
references.citation: Trends Mol Med. 2002 Jan;8(1):38-44
references.pmid: 11796265
references.citation: Stroke. 2002 Feb;33(2):600-5
references.pmid: 11823676